Drugs with this side effect
- 17-hydroxyprogesterone: postmarketing
- 18F-flutemetamol: 1%
- 2-hydroxysuccinaldehyde: 9.5%
- 4-AP: 7%
- 4-methylpyrazole
- 5-ASA: postmarketing, rare, 0.7% - 15%
- 5-FU
- 5-aza-2'-deoxycytidine: 12.3% - 21.2%
- 5-azacytidine: very common, 5.43% - 18.6%
- 8-MOP
- ACTH(1-39: postmarketing
- ALX 111
- AMD3100: common, 0% - 11%
- APAs
- Abarelix: 12.3%
- Anidulafungin
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 2% - 1-10%
- BPTI
- Benicar-HCT: 1% - 8%
- Buscopan
- CAS 76095-16-4: 4.3% - 7.9%
- CAS 76420-72-9: 7.9%
- CGP 19835A: very common, 17%
- Cancidas: 0% - 2.13%
- Cantril
- Carfilzomib: 0.19% - 12.5%
- Colimycin M
- DFMO: 1.3% - 1.5%
- Depreotide
- EACA
- Enfuvirtide
- Estrofem
- FK463: 0%
- FP-CIT: uncommon
- FTY720: common, 7% - 7.29%
- Fe(III: postmarketing, 0% - 13%
- Forteo: 8%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 6%
- Goserelin: 0% - 6%
- Histrelin
- Hoe 140: 2.6%
- ICI 182,780: 6.6% - 6.9%
- Implanon: 7.2%
- Insulin
- K779: 7% - 24%
- Kaluril
- L-threo-DOPS: 3.82% - 10%
- LY146032: postmarketing, common, 2% - 6.03%
- Leuprorelin: 5% - 7%
- LiOH
- Lisinopril: postmarketing, common, 4.4% - 19%
- Lovaza
- Lu AA21004: 6% - 9%
- Lutalyse
- Lyxumia
- MDV3100: 0.5% - 9.5%
- MK-462
- Madopar
- Meropenem anhydrous
- Mersyndol
- Metrodin: 0% - 2.5%
- MnDPDP
- N-methylscopolamine
- Nafarelin
- NuvaRing
- Nuvocid: 2.64% - 2.66%
- Octreotide: common, 8.33% - 14.9%
- Oestrogen: uncommon, 3% - 6%
- Optison: postmarketing, uncommon, 2.5%
- PCI-32765: 0% - 11%
- PGE1: 1% - 22%
- PGE2
- Paroven
- Photofrin: postmarketing
- Photofrin II: uncommon
- Revasc
- SOM230: 8.75% - 9.76%
- SU5416: 17%
- Sativex
- Saxagliptin
- Signifor: 8.75% - 9.76%
- SonoVue
- Stalevo 50
- Supremon: 5.5% - 8.93%
- Symlin
- T-A2-3
- TMC207
- TR-700: 2%
- Triptorelin: 1.4% - 2.9%
- Trisequens
- UDCA: postmarketing, 16.5%
- VACV: postmarketing, rare, uncommon, 1% - 31%
- Vancocine: postmarketing
- Zyprexa Relprevv: common
- abacavir: 4.92% - 4.95%
- acamprosate: 3% - 4%
- acebutolol: 2% - 12%
- acetaminophen: common, 2.7%
- acetazolamide
- acitretin: postmarketing
- acyclovir: common
- adenosine: 12%
- afatinib: 0% - 11%
- agomelatine
- albendazole: 1% - 1.2%
- alendronate: postmarketing, 0%
- alfentanil: 2.4%
- alfuzosin: common, 2.1% - 5.71%
- aliskiren: common
- allopurinol: postmarketing
- almotriptan: frequent, 3% - 4%
- alprazolam: frequent, 1.8% - 29.8%
- amantadine: uncommon, common
- ambrisentan: postmarketing, 6.92% - 8.96%
- amifostine
- amiloride
- aminoglutethimide
- aminophylline
- amiodarone
- amisulpride: 0% - 1%
- amitriptyline
- amlodipine: 1.1% - 3.4%
- amlodipine besylate
- amobarbital
- amoxapine
- amoxicillin: very rare, postmarketing
- amphetamine
- amphotericin B: 7% - 10.3%
- amsacrine: 1-10%
- anagrelide: 15% - 15.4%
- anastrozole: 4.31% - 7.63%
- anthracycline: 0% - 9%
- apomorphine: 20%
- apraclonidine: postmarketing
- aprepitant: 3.4% - 4.2%
- argatroban: 0% - 5%
- aripiprazole: 1% - 11%
- arsenic
- arsenic trioxide: very common
- articaine
- ascorbate
- asenapine: 3% - 11%
- atazanavir: uncommon, 1% - 8%
- atenolol: 3% - 13%
- atomoxetine: 5% - 8%
- atorvastatin: postmarketing
- atosiban
- atovaquone: 3% - 14.1%
- atropine: rare
- avanafil: 1% - 2%
- axitinib: 9%
- azathioprine
- azelastine: postmarketing, 2%
- azilsartan
- azilsartan medoxomil
- azithromycin: postmarketing, 1% - 3.9%
- aztreonam
- baclofen: common, 1.7% - 12%
- balsalazide
- belinostat: 0% - 10%
- benazepril: 3.6%
- benazeprilat: 3.6%
- bendamustine: 0%
- bendrofluazide
- benzathine penicillin
- benzonatate
- benzphetamine
- bepridil: 0.971% - 27.3%
- betahistine: rare
- betaxolol: postmarketing, 2.7% - 17.3%
- bexarotene: common, 10%
- bezafibrate: 2.3%
- bicalutamide: 7% - 10%
- bimatoprost: postmarketing, 0.5% - 1.2%
- bisacodyl
- bisoprolol: postmarketing, common, 2.9% - 4.9%
- boceprevir: very common, 10% - 16%
- bortezomib: 0% - 23.2%
- bosentan: 11%
- bosutinib: 0%
- bretylium
- brimonidine: uncommon, common
- brinzolamide: postmarketing
- bromazepam: postmarketing, 7.6%
- bromcresol green
- bromocriptine: postmarketing, common, 8% - 17%
- budesonide: 4.67% - 12.4%
- bumetanide: 1.1%
- bupivacaine: 0% - 11.3%
- buprenorphine: 2% - 16%
- bupropion: 0.5% - 22.3%
- buspirone: postmarketing, 1% - 12%
- busulfan: 26% - 30%
- butabarbital
- butorphanol: 4.4% - 25%
- cabazitaxel: 0% - 1%
- cabergoline: 8.3% - 27%
- cabozantinib: 0% - 14%
- calcium: postmarketing
- candesartan: 0.3%
- candesartan cilexetil: postmarketing, 0.3% - 2.8%
- capecitabine: 1% - 8%
- capsaicin
- captopril: 22%
- carbamazepine: postmarketing, common, very common, 6.81% - 44%
- carbidopa: 2.3% - 2.9%
- carbinoxamine
- carboprost
- carisoprodol: postmarketing, 6.81% - 7.85%
- carnitine: 10% - 18%
- carteolol
- carvedilol: 0.4% - 32.4%
- cefaclor: rare
- cefadroxil
- cefazolin
- cefdinir
- cefditoren
- cefepime
- cefixime: postmarketing, 3%
- cefpodoxime
- cefprozil: 1%
- ceftaroline
- ceftazidime: uncommon
- ceftobiprole
- ceftriaxone
- cefuroxime
- cefuroxime axetil
- celecoxib: 1% - 7%
- celiprolol
- cephalexin
- cephem
- cerivastatin: 2.1%
- cetirizine: postmarketing, 1.97% - 2%
- cevimeline: 4.1%
- chloroprocaine
- chlorpheniramine
- chlorpromazine
- chlorpropamide
- chlorthalidone: common
- chlorzoxazone
- choline theophyllinate
- ciclesonide: postmarketing, 0.1%
- cidofovir: postmarketing
- cilazapril: postmarketing, 3% - 8.2%
- cilostazol: 9% - 10%
- cimetidine: common, 1.3%
- cinacalcet: common, 10%
- cinoxacin
- ciprofloxacin: rare, uncommon, 1% - 2%
- citalopram: 2% - 10.3%
- cladribine: very common, 6% - 9%
- clarithromycin: postmarketing, common, 2%
- clemastine
- clindamycin: postmarketing
- clindamycin phosphate
- clobazam
- clobetasol: postmarketing
- clofarabine: common
- clofazimine
- clomiphene citrate
- clomipramine: common, very common, 41% - 54%
- clonazepam: 1% - 8%
- clonidine: 2% - 13.2%
- clopidogrel: postmarketing, uncommon, 0.1% - 2.4%
- clorazepate
- clozapine: 12% - 27%
- cobicistat: common
- codeine
- colestimide: uncommon
- colestipol
- colestyramine
- conjugated estrogens: postmarketing, 0% - 0.699%
- copolymer 1
- cortisol
- cosyntropin
- crizotinib: 0% - 22%
- cyanocobalamin
- cyclizine
- cyclobenzaprine: 3% - 19%
- cyclophosphamide: postmarketing, 1%
- cyproheptadine
- cyproterone
- cyproterone acetate
- cysteamine: 0% - 5%
- cytarabine: 18% - 21.4%
- dabigatran etexilate
- dabrafenib: 0% - 16%
- dalbavancin
- dalteparin
- danazol
- dantrolene: 0% - 3.33%
- dapagliflozin: 0.2%
- darifenacin: 0.89% - 2.1%
- darunavir: 0% - 2.29%
- dasatinib: 0% - 14%
- deferasirox: uncommon
- deferoxamine: very rare
- degarelix
- delamanid: 30.2%
- delavirdine
- delta 9-THC
- demeclocycline
- demethyl
- deprenyl: postmarketing, 7% - 11%
- desflurane: postmarketing, 1%
- desipramine
- desloratadine
- desmopressin: 0% - 3%
- desvenlafaxine: 10% - 16%
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing
- dexrazoxane
- dextromethorphan: common
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: postmarketing, common, 0% - 10%
- dicyclomine: postmarketing, 40%
- diethylpropion
- diflunisal
- digoxin: 4.88% - 6%
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing, 4%
- diltiazem: 1.5% - 10.2%
- dimenhydrinate
- dimercaptosuccinic acid
- diphenhydramine
- dipyridamole: 11.8% - 13.6%
- disopyramide
- disulfiram
- docetaxel: 0% - 16%
- dofetilide: 8%
- dolasetron: 1.28% - 12.5%
- dolutegravir: 1% - 5%
- domperidone
- donepezil: 0% - 8%
- dorzolamide: postmarketing
- dothiepin
- doxapram
- doxazosin: 5.3% - 20.7%
- doxepin: frequent, 0.898% - 2.12%
- doxercalciferol: 11.5%
- doxorubicin: common, 0% - 10.2%
- droperidol
- duloxetine: 6% - 17%
- dutasteride
- efavirenz: common, 0% - 10%
- eletriptan: 3% - 7%
- eliglustat: 0% - 8.49%
- eltrombopag: 14%
- elvitegravir: uncommon
- emtricitabine: postmarketing, common, 7%
- entacapone: common, 7.5% - 8%
- entecavir: uncommon, common, 1% - 4%
- ephedrine
- eplerenone: common, 3%
- eprosartan
- ergonovine
- eribulin
- erlotinib
- ertapenem: 0% - 2.1%
- erythromycin
- erythromycin lactobionate
- eslicarbazepine
- eslicarbazepine acetate
- esmolol: 3%
- esomeprazole magnesium
- estazolam: 7%
- estradiol: postmarketing, common, 0.575% - 7.78%
- estradiol cypionate
- estradiol valerate
- estrone
- ethambutol
- ethionamide
- ethosuximide
- ethotoin
- etodolac
- etoposide: 5%
- etoposide phosphate: 5%
- etoricoxib
- everolimus: 0% - 12%
- exemestane: common, 3% - 8-13%
- exenatide: 1.35% - 9%
- ezetimibe: postmarketing, 0.2% - 2.7%
- famciclovir: very rare, postmarketing, common, 0% - 2.41%
- famotidine: 1.2% - 1.3%
- febuxostat
- felbamate: 18.4%
- felodipine
- fenofibrate: 0.533% - 4.08%
- fenofibric acid: 0.816% - 4.08%
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 32.1%
- ferumoxytol: postmarketing, 1.8% - 2.6%
- fesoterodine: postmarketing
- fexofenadine: 0.8% - 2.1%
- fidaxomicin
- finasteride: 7.4% - 17.7%
- flecainide: 10.6% - 18.9%
- florbetapir: 0.4%
- flucloxacillin
- fluconazole: postmarketing, 0% - 1.3%
- flumazenil
- flunisolide
- flunitrazepam: common
- fluocinolone acetonide
- fluocinonide: postmarketing
- fluorescein: postmarketing, uncommon
- fluoxetine: very common, 2% - 13.3%
- flurazepam
- flurbiprofen
- flutamide
- fluticasone
- fluticasone furoate
- fluticasone propionate
- fluvastatin: postmarketing, 0.5% - 2.5%
- fluvoxamine: common, frequent, 2% - 15%
- fondaparinux: rare, 0.612% - 4.17%
- formoterol: very rare, uncommon, 1.6%
- fosamprenavir: common
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin: 1.3% - 2.2%
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fosphenytoin: 3.3% - 31.1%
- frovatriptan
- furosemide
- fusidic acid
- gabapentin: 0.6% - 30%
- gadobenate dimeglumine: postmarketing, 3.6%
- gadobutrol: 0.3%
- gadodiamide
- gadofosveset
- gadolinium: 0.5% - 3.74%
- gadopentetate: 1%
- gadoteridol: 0.25%
- gadoversetamide: 1.8% - 3.74%
- galantamine: 1% - 9%
- ganciclovir
- gatifloxacin
- gemeprost
- gemfibrozil: 2.8%
- gemifloxacin: 0.8% - 1.5%
- gentamicin
- gliclazide: 2.2% - 2.3%
- glimepiride: 1.7% - 13%
- glipizide: 6.8%
- glucose
- glutamine: 0% - 12.5%
- glycerol phenylbutyrate: 0% - 8.89%
- glycopyrrolate
- gold sodium thiomalate
- granisetron: common, 4.1% - 5%
- griseofulvin
- guaifenesin
- guanfacine: postmarketing, 1% - 15%
- halofantrine: 4.5% - 5%
- haloperidol
- hepatitis B vaccines: uncommon
- hexamethylmelamine
- histamine
- hydralazine: uncommon
- hydrochlorothiazide: 5.7%
- hydrocodone: 1.99% - 3.33%
- hydroflumethiazide
- hydromorphone: 2.24% - 10.6%
- hydroxocobalamin
- hydroxybutyrate: 9% - 23%
- hydroxychloroquine
- hydroxyurea: uncommon, 1%
- ibandronate: 1% - 4%
- ibuprofen: 4.28% - 14%
- icodextrin
- ifosfamide
- iloperidone: 10% - 20%
- iloprost: postmarketing
- imatinib: common, 0% - 24.4%
- imipramine: common
- imiquimod: uncommon, 0% - 2.5%
- indacaterol: postmarketing, common
- indapamide: 1.9% - 7%
- indinavir: 0.5% - 10.7%
- indomethacin: 10% - 15%
- insulin detemir: 0.9% - 1.8%
- iodipamide
- iodixanol
- iohexol
- iopamidol
- iopromide: 0.1%
- iotrolan: 1.9%
- ioxilan
- ipratropium bromide: common, 0% - 3.9%
- irbesartan: common, 0.4% - 7.6%
- irbesartan-hydrochlorothiazide: 0.4% - 7.6%
- irinotecan: 0% - 21.1%
- iron sucrose: 5.5% - 6.6%
- isocarboxazid
- isomannide
- isopropyl unoprostone
- isoproterenol
- isosorbide dinitrate
- isosorbide-5-mononitrate: common
- isoxsuprine
- isradipine: 7.3% - 8.2%
- itraconazole: postmarketing, 0% - 4%
- ivabradine
- ivacaftor: 5% - 9.17%
- ivermectin: 1% - 10%
- ixabepilone: 0% - 7%
- ketoconazole
- ketoprofen
- ketorolac: 7%
- ketorolac tromethamine: postmarketing, 7%
- ketotifen
- labetalol: 4% - 16.9%
- lacosamide: 16% - 60%
- lamivudine: 3.9% - 10.4%
- lamotrigine: 0% - 54%
- lanreotide
- lansoprazole: 1.1% - 3%
- latanoprost
- leflunomide: postmarketing, common, 3% - 7%
- lenalidomide: postmarketing, very common, 1.98% - 23.2%
- lercanidipine: very common, 0% - 1%
- letrozole: common, 0.0252% - 14.2%
- leuprorelin acetate: 0% - 18.3%
- levetiracetam: 1% - 9.2%
- levobunolol
- levodopa/carbidopa: 2.9%
- levonorgestrel: postmarketing, 3.7% - 23.1%
- levosimendan
- lidocaine
- linaclotide
- lindane
- linezolid: 0.3% - 3%
- liraglutide: postmarketing
- lisdexamfetamine dimesylate: postmarketing, 5%
- lisuride
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin: 2.1%
- lomitapide
- loperamide: postmarketing, 1.4%
- loratadine
- lorazepam: 6.9%
- lorcaserin: 7.03% - 8.45%
- lormetazepam
- losartan: 3% - 4.1%
- lovastatin: postmarketing, 0.5% - 1.2%
- loxapine: common
- lubiprostone: 3%
- lurasidone: 4% - 6%
- lymecycline
- mTHPC: common
- malvidin
- mannitol: 0.478% - 3.1%
- maprotiline: 8%
- maraviroc: 8.2% - 9%
- mebeverine
- medroxyprogesterone: 5.6%
- medroxyprogesterone acetate: 6%
- mefenamic acid
- mefloquine: postmarketing
- megestrol acetate
- melatonin
- meloxicam: 0% - 3.8%
- memantine: 5% - 7%
- meperidine
- mephenytoin
- mepivacaine
- meprobamate
- meropenem
- mesna: 4.2% - 9%
- metaiodobenzylguanidine
- metaproterenol: 2.4% - 12%
- metaxalone
- metformin
- methadone
- methamphetamine
- methocarbamol
- methotrexate: 1-10%
- methsuximide
- methyclothiazide
- methyl aminolevulinate
- methyldopa
- methylene blue
- methylene diphosphonate
- methylergometrine
- methylnaltrexone: common
- methylphenidate: postmarketing, common, 0% - 7.4%
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metipranolol
- metoclopramide: postmarketing
- metolazone: 10.2%
- metoprolol: common, 1.8%
- metronidazole: very rare, postmarketing, 1% - 10%
- metyrapone: common
- mexiletine: 2.9% - 26.4%
- mianserin
- midazolam
- midodrine
- mifepristone: 22%
- miglustat: 0% - 25%
- milnacipran: 10% - 11%
- minocycline: 8.75%
- mirabegron: 0.5% - 2.7%
- mirtazapine: postmarketing, 7% - 7.28%
- misoprostol: postmarketing
- mitotane: 15%
- mivacurium
- moclobemide
- modafinil: postmarketing, 5%
- moexiprilat: 0.4% - 4.3%
- montelukast: postmarketing, 1.9%
- morphine: postmarketing, 6%
- moxifloxacin: 0.5% - 3%
- moxonidine: postmarketing
- mupirocin
- mycophenolate mofetil: 5.7% - 28.7%
- mycophenolic acid: 27.7% - 28.7%
- nabilone: postmarketing
- nabumetone: 6%
- nadolol: 3%
- naftifine: postmarketing
- nalbuphine
- nalidixic acid
- nalmefene: 3% - 4%
- naltrexone: postmarketing, 4%
- naphazoline
- naproxen: postmarketing
- naratriptan: 1% - 5%
- nateglinide: 2.2% - 3.6%
- nebivolol: 2% - 4%
- nedocromil sodium
- nefazodone: 1.9%
- nelarabine: 0% - 21%
- nelfinavir
- neostigmine
- nepafenac: rare
- nesiritide: 2% - 6%
- niacin: postmarketing
- nicardipine: 0.288% - 3.3%
- nicorandil: common
- nicotine
- nifedipine: 2.3% - 27%
- nilotinib: common
- nilutamide: 7.1%
- nimodipine
- nisoldipine: 3% - 7%
- nitazoxanide
- nitrazepam
- nitric oxide: postmarketing
- nitrite
- nitrofurantoin
- nitroglycerin: very rare, rare
- nitroprusside
- nitrous oxide
- nizatidine: 4.6%
- norethisterone
- norfloxacin: 1.2% - 2.6%
- nortriptyline
- ofloxacin: 0% - 1%
- ogen
- olanzapine: common, 1% - 18%
- olmesartan: common, 0% - 3.08%
- olmesartan medoxomil
- olodaterol: 2.28%
- olopatadine: postmarketing
- olsalazine: 1%
- omeprazole: uncommon, 1.07% - 2.8%
- ondansetron: postmarketing, rare, 0.01% - 12.2%
- orlistat: uncommon, 5.2%
- orphenadrine
- oseltamivir: postmarketing, 2.1% - 15%
- oxaliplatin: 7% - 8%
- oxaprozin
- oxazepam
- oxcarbazepine: very common, 1.3% - 49%
- oxprenolol
- oxybutynin: postmarketing, common, 1.5% - 16.6%
- oxycodone: 13% - 16%
- oxymorphone: 0% - 18%
- paclitaxel: very rare, postmarketing, common
- paliperidone: common, 2% - 6%
- palonosetron: 1.26% - 2.2%
- pamidronate: uncommon
- pantoprazole: uncommon, 1.4% - 3%
- paraldehyde
- parecoxib
- paricalcitol: 4% - 6.6%
- paroxetine: postmarketing, common, 0.6% - 14%
- pazopanib: 0% - 11%
- pegaptanib
- pegaptanib sodium
- pemetrexed
- penbutolol: 0.4% - 4.9%
- penciclovir: postmarketing
- penicillin
- pentamidine
- pentazocine
- pentobarbital
- pentosan polysulfate: 1%
- pentostatin
- pentoxifylline: 1.9% - 11.9%
- perampanel: 16% - 43%
- pergolide: frequent, 19.1%
- perhexiline
- perindopril
- perindopril erbumine: 6% - 8.6%
- perindoprilat
- permethrin
- perphenazine
- phendimetrazine
- phenelzine
- phenobarbital
- phentermine
- phentolamine: postmarketing, common
- phenylpropanolamine
- phenytoin: 3.3% - 31.1%
- phosphate
- pilocarpine: 5% - 12%
- pimozide: postmarketing, 0%
- pindolol: 1% - 11%
- pioglitazone
- piperacillin
- pirbuterol: 0% - 1.2%
- pirfenidone
- piroxicam: 4.1%
- pitavastatin: postmarketing
- pixantrone
- pizotifen
- podophyllotoxin
- polymyxin B
- polythiazide
- pomalidomide: 17% - 19.6%
- ponatinib: 0% - 11%
- posaconazole
- potassium phosphate
- pralidoxime
- pramipexole: common, very common, 2% - 26%
- prasugrel: 4.1% - 4.6%
- pravastatin: 1% - 7.3%
- praziquantel
- prazosin
- prednisolone phosphate
- prednisone
- pregabalin: 3% - 38%
- prilocaine
- primidone
- probenecid
- procainamide
- procaine
- procarbazine
- prochlorperazine
- progesterone: postmarketing, 4% - 24%
- promethazine
- propafenone: postmarketing, 1.7% - 23%
- propantheline
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol: 3.53% - 6.74%
- prostacyclin: 8% - 83%
- protriptyline
- prucalopride: common
- pyrantel
- quazepam: 2%
- quetiapine: 1% - 19%
- quinapril
- quinaprilat
- quinidine: 3%
- rabeprazole
- raltegravir
- ramelteon: 0.5% - 5%
- ramipril: 0.5% - 5.6%
- ramiprilat: 0.5% - 4%
- ranitidine
- ranolazine: 3.58% - 6.2%
- rapamycin: 11%
- rasagiline: 7%
- reboxetine: 9.49%
- regadenoson: very common, 7% - 11%
- remifentanil: 0% - 5.03%
- rescinnamine
- reserpine
- retigabine: 6% - 32%
- retinoic acid: postmarketing, 20%
- ribavirin: very common, 13% - 26%
- rifampicin
- rifapentine
- rifaximin: 12.9%
- rilpivirine: 1% - 7%
- riluzole: 3.8% - 12.7%
- rimantadine: 0.7% - 2.1%
- rimonabant
- riociguat: 20%
- risedronate: 1.6% - 6.7%
- risperidone: 0.2% - 16%
- ritonavir: 1.7% - 5.2%
- rivaroxaban
- rivastigmine: common, 0% - 21%
- rizatriptan: 4% - 9%
- rofecoxib: 2.2% - 3.4%
- roflumilast: 2.07%
- ropinirole: 0.8% - 40%
- ropivacaine: 1.1% - 10%
- rosiglitazone
- rosuvastatin: common, 4%
- rotigotine: 7% - 23%
- roxithromycin
- rufinamide: 3% - 19%
- ruxolitinib: very common, 0% - 18.1%
- salbutamol: postmarketing, 0% - 7%
- salicylate
- salmeterol: 4%
- salmon calcitonin acetate: postmarketing, common
- samarium: 4.02%
- saquinavir: common
- scopolamine: postmarketing
- secobarbital
- sertraline: postmarketing, rare, common, 1% - 17%
- sevoflurane
- sibutramine
- sildenafil: postmarketing, common, 1% - 2%
- silodosin: 3.22%
- simvastatin: postmarketing
- sitagliptin: postmarketing, uncommon
- sitaxsentan: common
- sodium
- sodium acetate
- sodium cromoglycate
- sodium ferric gluconate: 13%
- sodium nitrite
- sodium nitroprusside
- sofosbuvir: very common
- solifenacin: 1.8% - 1.9%
- sotalol: 1% - 20%
- sparfloxacin: 2% - 3.8%
- spectinomycin
- spironolactone
- stavudine
- strontium ranelate: postmarketing
- sufentanil: 2%
- sugammadex
- sulfasalazine: 4%
- sulindac
- sumatriptan: common, 1% - 12%
- sunitinib: 15%
- suvorexant: 3%
- tacrolimus: common, 4.5% - 19%
- tadalafil: 1% - 8%
- tamoxifen: 7.56% - 7.63%
- tamsulosin: postmarketing, common, 1.3% - 17.1%
- tapentadol: 17% - 24%
- technetium-99m
- tegaserod: 1% - 4%
- telavancin: common, 6%
- telithromycin: 1.5% - 3.7%
- telmisartan: postmarketing, common, 3.6%
- temazepam: 3.3% - 4.5%
- temozolomide: common, 0% - 12%
- temsirolimus
- tenofovir: 1% - 13%
- tenofovir disoproxil fumarate: postmarketing, very common, 1% - 13%
- tenoxicam: common
- terazosin: 2% - 19.3%
- terbinafine: very rare, common
- terbutaline: 1.3% - 10.2%
- terconazole: postmarketing
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetrabenazine
- tetracaine
- tetraen
- tetrahydrobiopterin
- tetrofosmin: 7%
- thalidomide: 0% - 19.6%
- theophylline
- thiabendazole
- thiazide
- thiotepa: 1-10%
- thymidine: 0.7% - 5.05%
- tiagabine: 1.7% - 31%
- tiaprofenic acid: 2.4% - 3.9%
- tibolone
- ticagrelor: 3.9% - 4.5%
- ticlopidine
- tigecycline: common, 2.7% - 3.5%
- tiludronate
- timolol: 1% - 6%
- tinidazole: 0.5% - 1.1%
- tiotropium: postmarketing
- tipranavir: uncommon
- tirofiban: 2%
- tizanidine: postmarketing, 2% - 45%
- tobramycin: common, 5.8%
- tolazamide
- tolcapone: 13%
- tolmetin
- tolterodine: 1.8%
- tolvaptan: common
- topiramate: postmarketing, 0% - 34.1%
- topotecan: common
- torasemide: 3.2%
- toremifene: 7% - 9%
- trabectedin
- tramadol: postmarketing, rare, very common, 7.41% - 33%
- tramazoline
- trametinib: 0% - 16%
- trandolapril: 1.7% - 23%
- trandolaprilat: 23%
- tranexamic acid: postmarketing
- tranylcypromine
- travoprost: rare, uncommon
- trazodone: 3.47% - 28%
- treprostinil: 9%
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing
- triamterene
- triazolam: 7.8%
- trifluoperazine
- trihexyphenidyl
- trimethobenzamide
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trimipramine
- tropisetron: 0.334% - 1.15%
- trospium chloride: postmarketing
- trovafloxacin: 2% - 11%
- ulipristal: 5%
- umeclidinium
- unoprostone
- ustekinumab: common, 1%
- v 1784: postmarketing, 6% - 8%
- valdecoxib: 2.6% - 4.2%
- valganciclovir: 6% - 10%
- valproate: 5.2% - 25%
- valrubicin
- valsartan: common, 2% - 17%
- vandetanib
- vardenafil: 2% - 2.3%
- varenicline: frequent
- vemurafenib: postmarketing, common
- venlafaxine: postmarketing, common, 2% - 23.9%
- verapamil: 1.2% - 4.7%
- vernakalant
- verteporfin
- vigabatrin: common, 24% - 26%
- vilazodone: 9%
- vildagliptin: common
- vinblastine
- vincristine
- vinflunine
- vinorelbine: 0% - 3%
- vitamin K
- voriconazole: common, 0% - 2.55%
- vorinostat
- warfarin
- zafirlukast: 1.6%
- zalcitabine
- zaleplon: 7% - 9%
- zanamivir: 1% - 2%
- ziconotide: 42% - 46%
- zidovudine: postmarketing, common, 6% - 20.8%
- zidovudine/lamivudine: 3.9% - 10.4%
- zileuton
- ziprasidone: 3% - 16%
- zoledronic acid: uncommon, 2% - 9%
- zolmitriptan: 3% - 10%
- zolpidem: postmarketing, common, 0.4% - 12%
- zonisamide: 13%
- zopiclone: 1% - 7%
- zuclopenthixol
|
Drugs with this indication
|
